Phase II TPDCV protocol for pediatric low-grade hypothalamic/chiasmatic gliomas: 15-year update

To report long-term results for children with low-grade hypothalamic/chiasmatic gliomas treated on a phase II chemotherapy protocol. Between 1984 and 1992, 33 children with hypothalamic/chiasmatic LGGs received TPDCV chemotherapy on a phase II prospective trial. Median age was 3.0 years (range 0.3–1...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishra, Kavita K., Squire, Sarah, Lamborn, Kathleen, Banerjee, Anuradha, Gupta, Nalin, Wara, William M., Prados, Michael D., Berger, Mitchel S., Haas-Kogan, Daphne A.
Formato: Texto
Lenguaje:English
Publicado: Springer US 2010
Materias:
Clinical Study - Patient Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951507/
https://www.ncbi.nlm.nih.gov/pubmed/20221671
http://dx.doi.org/10.1007/s11060-010-0151-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951507/
https://www.ncbi.nlm.nih.gov/pubmed/20221671
http://dx.doi.org/10.1007/s11060-010-0151-7

Ejemplares similares